David Windley
Stock Analyst at Jefferies
(4.51)
# 307
Out of 4,734 analysts
187
Total ratings
65.74%
Success rate
13.84%
Average return
Main Sectors:
Stocks Rated by David Windley
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CNC Centene | Downgrades: Underperform | $68 → $52 | $62.25 | -16.47% | 26 | Dec 10, 2024 | |
OSCR Oscar Health | Initiates: Underperform | $12 | $15.90 | -24.53% | 1 | Dec 10, 2024 | |
HUM Humana | Downgrades: Hold | $419 → $253 | $282.63 | -10.48% | 18 | Oct 7, 2024 | |
FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $17.69 | +18.71% | 2 | Sep 25, 2024 | |
MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $337.35 | +2.27% | 5 | Sep 25, 2024 | |
CI The Cigna Group | Maintains: Buy | $402 → $422 | $283.99 | +48.60% | 17 | Sep 17, 2024 | |
MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $286.21 | +3.77% | 23 | Jul 24, 2024 | |
IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $197.36 | +22.62% | 4 | Jul 24, 2024 | |
UNH UnitedHealth Group | Upgrades: Buy | $481 → $647 | $509.76 | +26.92% | 26 | Jul 17, 2024 | |
NOTV Inotiv | Downgrades: Hold | $12 → $3.75 | $4.27 | -12.18% | 4 | May 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $385.29 | +56.77% | 1 | Apr 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $592.64 | -36.72% | 1 | Apr 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $12.98 | +19.41% | 3 | Mar 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $216.59 | +24.66% | 2 | Mar 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $11.66 | +32.93% | 3 | Mar 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $336.34 | +59.36% | 10 | Feb 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $22.85 | +26.91% | 2 | Nov 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $163.50 | +24.16% | 19 | Mar 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $198.11 | +52.44% | 14 | Sep 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $9.09 | +2,628.27% | 1 | Feb 25, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.70 | - | 5 | Oct 9, 2017 |
Centene
Dec 10, 2024
Downgrades: Underperform
Price Target: $68 → $52
Current: $62.25
Upside: -16.47%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $15.90
Upside: -24.53%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $282.63
Upside: -10.48%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $17.69
Upside: +18.71%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $337.35
Upside: +2.27%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $283.99
Upside: +48.60%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $286.21
Upside: +3.77%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $197.36
Upside: +22.62%
UnitedHealth Group
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $509.76
Upside: +26.92%
Inotiv
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $4.27
Upside: -12.18%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $385.29
Upside: +56.77%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $592.64
Upside: -36.72%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $12.98
Upside: +19.41%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $216.59
Upside: +24.66%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $11.66
Upside: +32.93%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $336.34
Upside: +59.36%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $22.85
Upside: +26.91%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $163.50
Upside: +24.16%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $198.11
Upside: +52.44%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $9.09
Upside: +2,628.27%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.70
Upside: -